Skip to main content
Estimate

These guides are AI-generated educational summaries — not legal or medical advice.

C&P Exam Prep: Urinary Tract Conditions (BPH / Bladder / Kidney)

DC 7528 genitourinary 38 CFR 4.115a / 4.115b

DBQ Overview

Interview + Physical
Form Name
Urinary_Tract_Conditions
Form Code
Urinary_Tract_Conditions
Page Count
7
Examiner Type
Urologist or Physician
Estimated Duration
20-30 minutes
Exam Format
Interview + Physical

What to Expect During Your Exam

Exam Overview

To document the current severity, frequency, and functional impact of urinary tract conditions including BPH, bladder dysfunction, kidney impairment, or residuals of malignant genitourinary neoplasms for VA disability rating purposes under 38 CFR 4.115a and 4.115b, Diagnostic Code 7528.

What the examiner evaluates:

  • Current diagnosis and ICD code for urinary tract conditions
  • Voiding dysfunction - presence, type, severity, and frequency
  • Daytime voiding interval (how often urination occurs during the day)
  • Nighttime awakenings to void (nocturia frequency)
  • Obstructive voiding symptoms: hesitancy, weak stream, slow stream, decreased force of stream
  • Post-void residual urine volume (PVR > 150cc is clinically significant)
  • Uroflowmetry peak flow rate (< 10 cc/sec is clinically significant)
  • Urinary incontinence - type (stress, urge, overflow) and severity
  • Requirement for appliance use (catheter, condom catheter, pads, diapers)
  • History of urinary tract infections - frequency, recurrence, whether secondary to obstruction
  • Bladder or urethral stricture disease - presence and frequency of required dilation
  • History of bladder fistula, diverticulum, neurogenic or severely dysfunctional bladder
  • History of bladder injury, suprapubic cystotomy, or other bladder surgery
  • Renal dysfunction attributable to urinary tract conditions
  • History of malignant neoplasm - current status, recurrence, metastasis
  • Neoplasm treatment history: surgery, radiation, chemotherapy, dates
  • Current treatment regimen: medications, diet therapy, suppressive drug therapy
  • Drainage requirements: catheterization, stent, or nephrostomy tube
  • Functional impact on occupational and daily activities
  • Diagnostic test results: urinalysis, PSA, uroflowmetry, imaging, biopsy

Exam is typically conducted in person at a VA facility or contracted exam site (QTC, LHI, VetFed). Telehealth or records review may occur in limited circumstances. If conducted remotely, the method will be documented on the DBQ. Bring all relevant outside medical records, imaging reports, and a written symptom summary. You have the right to request recording of the exam in most states - check your state law and notify the examiner in advance.

Typical duration: 20-30 minutes

Voiding Frequency Assessment (Daytime Voiding Interval)

How often you urinate during waking hours. Normal is approximately every 3-4 hours. The DBQ specifically captures intervals less than 1 hour, 1-2 hours, and 2-3 hours.

What to expect:

The examiner will ask how many times per day you urinate and how long you can go between voids. Track this for at least one week before your exam, especially on your worst days.

Key thresholds:

  • Daytime voiding every 1-2 hours — Correlates with moderate voiding dysfunction severity; supports higher disability ratings under 38 CFR 4.115b
  • Daytime voiding more frequently than every 1 hour — Indicates severe voiding dysfunction; critical for maximum rating consideration
  • Daytime voiding every 2-3 hours — Correlates with mild to moderate voiding dysfunction

Tips:

  • Keep a bladder diary for 3-7 days before your exam recording exact voiding times
  • Report your average pattern AND your worst days - both are relevant
  • Note any urgency that forces you to void before you are 'ready'

Pain considerations: Report any burning, pressure, pelvic pain, or discomfort associated with urination, as these symptoms compound the functional impact and may support additional ratings.

Nocturia Assessment (Nighttime Awakenings to Void)

How many times per night you wake up specifically to urinate. The DBQ captures 0, 1, 2, 3, or more awakenings per night.

What to expect:

The examiner will ask how many times per night you wake to urinate. This is a key rating factor - document your actual nightly pattern over the week before your exam.

Key thresholds:

  • 3 or more nighttime awakenings — Indicates severe voiding dysfunction; important for higher rating levels under 38 CFR 4.115b
  • 2 nighttime awakenings — Indicates moderate-to-severe dysfunction; supports elevated rating
  • 1 nighttime awakening — Mild dysfunction; note any sleep disruption impact even at this level

Tips:

  • Track exact waking times in a sleep log for the week before the exam
  • Note whether nocturia disrupts sleep quality and causes daytime fatigue
  • Report your worst nights, not just your average - per M21-1 'worst day' reporting guidance

Pain considerations: Note if urgency on awakening causes rushing and any associated falls, near-falls, or safety incidents.

Uroflowmetry (Peak Flow Rate)

The speed at which urine exits the bladder. A peak flow rate less than 10 cc/sec is a clinically significant finding directly captured on the DBQ and associated with obstructive voiding.

What to expect:

You may be asked to urinate into a special funnel-shaped device that measures flow rate. This may or may not be performed at the C&P exam itself - results from prior urological evaluations are also used.

Key thresholds:

  • Peak flow rate < 10 cc/sec — This is a specific checkbox on the DBQ (field: UROFLOWMETRYPEAKFLOWRATELESSTHAN10CCSEC) and directly supports a finding of obstructive voiding dysfunction

Tips:

  • Bring any prior uroflowmetry results from your urologist to the exam
  • If this test has been performed at the VA, ensure the examiner has access to those records
  • Ask your treating urologist to document peak flow rate in their records prior to your exam

Pain considerations: Note if straining to void causes pelvic pain, perineal discomfort, or suprapubic pressure.

Post-Void Residual (PVR) Measurement

The amount of urine remaining in the bladder after urination. A PVR greater than 150 cc is a specific DBQ threshold indicating incomplete bladder emptying.

What to expect:

This is typically measured by ultrasound (bladder scan) after you void. It may be performed at the C&P exam or referenced from prior medical records.

Key thresholds:

  • PVR > 150 cc — Specific DBQ checkbox (field: POSTVOIDRESIDUALSGREATERTHAN150CC); supports finding of significant voiding dysfunction and risk of urinary retention complications

Tips:

  • Request PVR measurement from your treating urologist before the exam if not recently done
  • Bring documentation of any prior PVR results
  • Note any symptoms of incomplete emptying: dribbling, double voiding, sense of retained urine

Pain considerations: Urinary retention and high PVR can cause suprapubic discomfort and increased UTI risk - document both.

Symptom Severity Assessment (Voiding Dysfunction)

Overall severity classification of voiding dysfunction: mild, moderate, or severe. The DBQ field (RG_3C_Severity) captures this as a direct rating determinant.

What to expect:

The examiner will synthesize your reported symptoms, test results, and treatment requirements to classify severity. Be specific and consistent across all symptom descriptions.

Key thresholds:

  • Severe voiding dysfunction — Supports highest disability ratings; may include requirement for appliance, catheter use, or continuous management
  • Moderate voiding dysfunction — Supports mid-range ratings; characterized by significant frequency, nocturia, and obstructive symptoms
  • Mild voiding dysfunction — Supports lower ratings; symptoms present but with less functional impairment

Tips:

  • Prepare a written summary of all urinary symptoms with frequency and severity before the exam
  • Describe impact on work, sleep, social activities, and travel
  • Use your worst days as your benchmark per M21-1 guidance - do not report only your best days

Pain considerations: Describe any pelvic, perineal, or lower abdominal pain associated with voiding dysfunction as this increases the overall functional impact.

Estimate

Rating Criteria Breakdown

100% Active malignant neoplasm of the genitourinary system under ...

Active malignant neoplasm of the genitourinary system under DC 7528. Rated at 100% while the malignancy is active (during active treatment or if untreated). After no local recurrence or metastasis, rating is based on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.

Key Symptoms

  • Active malignant neoplasm confirmed by biopsy or imaging
  • Ongoing treatment: surgery, radiation therapy, antineoplastic chemotherapy
  • Significant functional impairment from disease or treatment
  • Metastatic disease
  • Post-treatment residuals including severe voiding dysfunction or renal dysfunction

CFR: 38 CFR 4.115b, DC 7528: Malignant neoplasms of the genitourinary system - rated 100% while active. After no local recurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.

60% Voiding dysfunction - requires the use of an appliance (cath ...

Voiding dysfunction - requires the use of an appliance (catheter, condom catheter, or similar device) for management of urinary function. Alternatively, renal dysfunction at the severe level may also reach this threshold. This rating level reflects the most severe residual voiding dysfunction after malignancy treatment.

Key Symptoms

  • Requires use of catheter (intermittent or indwelling) for bladder management
  • Requires condom catheter or external collection device
  • Requires absorbent pads or diapers due to continuous or severe incontinence
  • Continuous catheter drainage required
  • Neurogenic or severely dysfunctional bladder
  • Suprapubic cystotomy present

CFR: 38 CFR 4.115b: Voiding dysfunction rated based on requirement for appliance use. Neurogenic or severely dysfunctional bladder requiring catheterization supports maximum voiding dysfunction ratings.

40% Voiding dysfunction - marked obstructive or irritative voidi ...

Voiding dysfunction - marked obstructive or irritative voiding symptoms with daytime voiding frequency every 1-2 hours, nocturia 3 or more times per night, or obstructive signs such as uroflowmetry peak flow rate less than 10 cc/sec and post-void residuals greater than 150 cc. Recurrent symptomatic UTIs secondary to obstruction also support this level.

Key Symptoms

  • Daytime voiding interval of 1-2 hours
  • Nocturia 3 or more times per night
  • Uroflowmetry peak flow rate < 10 cc/sec
  • Post-void residual > 150 cc
  • Recurrent UTIs secondary to obstruction
  • Hesitancy, weak stream, decreased force of stream
  • Stricture disease requiring frequent dilation
  • Continuous intensive management required

CFR: 38 CFR 4.115b: Voiding dysfunction causing marked frequency (voiding every 1-2 hours daytime, 3+ times nocturia), obstructive voiding signs on objective testing, or recurrent infections secondary to obstruction.

20% Voiding dysfunction - moderate obstructive or irritative sym ...

Voiding dysfunction - moderate obstructive or irritative symptoms. Daytime voiding every 2-3 hours, nocturia 2 times per night, or moderate obstructive signs. Recurrent symptomatic UTIs (urinary tract infections) requiring treatment. Stricture disease requiring periodic dilation.

Key Symptoms

  • Daytime voiding interval of 2-3 hours
  • Nocturia 2 times per night
  • Recurrent symptomatic UTIs
  • Moderate obstructive voiding symptoms
  • Stricture disease requiring periodic dilation
  • Drug therapy required for management

CFR: 38 CFR 4.115b: Voiding dysfunction with moderate frequency (every 2-3 hours daytime, nocturia twice nightly) or recurrent symptomatic infections requiring ongoing treatment.

0% Voiding dysfunction - mild or infrequent symptoms that do no ...

Voiding dysfunction - mild or infrequent symptoms that do not meet the threshold for a compensable rating. Condition is diagnosed and service-connected but causes minimal functional impairment on current evaluation. This rating is non-compensable but preserves service connection for future increases.

Key Symptoms

  • Diagnosed condition with mild intermittent symptoms
  • Occasional hesitancy or mild nocturia (once per night)
  • No significant obstructive signs on objective testing
  • No appliance requirement
  • No recurrent UTIs
  • Managed with diet therapy or mild medication only

CFR: 38 CFR 4.115b: Voiding dysfunction present but not meeting compensable criteria. Preserves service connection; future worsening can be addressed with an increase claim.

How to Describe Your Symptoms

Daytime Urinary Frequency

How to describe:

State the exact number of times you urinate during waking hours on a typical day AND on your worst days. Use specific times if possible (e.g., 'I urinate every 45 minutes on bad days and every 90 minutes on good days'). Explain what limits your voiding interval - urgency, inability to hold, fear of leakage.

Worst-day example:

“On my worst days, I need to urinate every 30-45 minutes. I cannot sit through a one-hour meeting without leaving. I plan all activities around bathroom access and have turned down social invitations because I cannot be away from a restroom for more than 20-30 minutes.”

What the examiner listens for:

Specific voiding intervals, urgency severity, impact on work attendance and social function, whether frequency is driven by urgency or incomplete emptying.

Understatements to avoid:

Do not say 'I go to the bathroom a lot' without specifying how often. Do not report only your best days. Do not minimize by saying 'it's not that bad' if it affects your daily activities.

Nocturia (Nighttime Voiding)

How to describe:

Report the exact number of times you wake specifically to urinate each night. Distinguish nocturia from waking for other reasons. Describe the impact on sleep quality, daytime fatigue, cognitive function, and any safety hazards from rushing to the bathroom at night.

Worst-day example:

“On my worst nights I wake up 4-5 times to urinate. I cannot get more than 1-2 hours of uninterrupted sleep. The next day I am exhausted and unable to concentrate at work. I have nearly fallen twice rushing to the bathroom in the dark.”

What the examiner listens for:

Exact number of awakenings, sleep disruption, daytime consequences of poor sleep, urgency associated with nighttime voiding, safety concerns.

Understatements to avoid:

Do not round down to a smaller number. Do not omit nights where nocturia is worse than average. Do not fail to mention safety hazards or sleep deprivation consequences.

Obstructive Voiding Symptoms (Hesitancy, Weak/Slow Stream, Straining)

How to describe:

Describe the difficulty initiating urination, reduced stream force, need to strain or push to void, post-void dribbling, and sensation of incomplete emptying. Quantify wait time before stream starts if applicable.

Worst-day example:

“On bad days I stand at the toilet for 1-2 minutes before any urine starts. When it does start, the stream is weak and dribbles rather than flowing. I have to push and strain to void anything. Even after finishing I feel like I have not emptied completely and return to the bathroom within minutes.”

What the examiner listens for:

Duration of hesitancy, stream characteristics, straining, double voiding, sensation of incomplete emptying, any associated pain or discomfort.

Understatements to avoid:

Do not omit post-void dribbling or double voiding. Do not fail to mention straining if you experience it - this is clinically significant and captured on the DBQ.

Urinary Incontinence

How to describe:

Specify the type: stress incontinence (leakage with coughing, sneezing, lifting), urge incontinence (sudden uncontrollable urge followed by leakage), overflow incontinence (constant dribbling from overfull bladder), or mixed. State frequency, volume of leakage, and whether you use pads or protective garments and how often you change them.

Worst-day example:

“I wear absorbent pads every day. On bad days I change them 3-4 times because of leakage. I have had full accidents while walking to the bathroom after feeling the urge. I have stopped exercising because any exertion causes leakage. I carry a change of clothes when I leave the house.”

What the examiner listens for:

Type of incontinence, frequency and volume of episodes, use and frequency of appliances or protective garments, impact on hygiene, social life, and ability to work.

Understatements to avoid:

Do not omit appliance or pad use. Do not minimize accidents as 'just a little leakage.' Do not fail to mention social withdrawal or activity restriction caused by incontinence.

Urinary Tract Infections (UTIs)

How to describe:

Report the number of symptomatic UTIs per year, symptoms experienced (burning, frequency urgency, fever, back pain), whether they required antibiotic treatment or hospitalization, and whether they are related to obstruction, catheter use, or incomplete emptying.

Worst-day example:

“I have had 6-8 UTIs in the past year. Each one requires antibiotics and I typically feel very ill for 3-5 days - burning with every void, fever, chills, and inability to work. Twice I was hospitalized for kidney infections. I am currently on suppressive antibiotic therapy to try to prevent recurrences.”

What the examiner listens for:

Annual frequency of UTIs, whether they are symptomatic, treatment required (antibiotics, hospitalization), whether secondary to obstruction or catheter use, current suppressive therapy.

Understatements to avoid:

Do not undercount infections by only reporting the ones you remember well. Bring medical records showing all UTI diagnoses and treatments. Do not omit hospitalizations for urinary infections.

Functional Impact on Daily Life and Work

How to describe:

Describe specific ways your urinary condition limits your ability to perform your job, engage in social activities, travel, exercise, sleep, and perform activities of daily living. Be concrete - give examples of things you cannot do or have stopped doing because of your condition.

Worst-day example:

“I cannot work a full day without multiple unplanned bathroom breaks that my employer has documented as disruptive. I cannot attend my children's events if bathrooms are not immediately available. I have stopped all travel because I cannot manage long periods without bathroom access. My condition has caused me significant embarrassment and I have withdrawn from social activities.”

What the examiner listens for:

Specific functional limitations, occupational impact, social withdrawal, travel restrictions, hygiene management burden, psychological impact.

Understatements to avoid:

Do not give vague answers like 'it affects my life.' Give specific examples. Do not omit occupational impact - the examiner is required to document this on the DBQ.

Malignancy History and Residuals

How to describe:

If your claim involves DC 7528, clearly state the type and location of the malignancy, date of diagnosis, all treatments received (surgery, radiation, chemotherapy), current status (active, in remission, no evidence of recurrence), and all residual symptoms from the disease or its treatment.

Worst-day example:

“I was diagnosed with bladder cancer in [year] and underwent surgery and radiation. While my cancer is currently in remission, I experience severe urinary incontinence, burning with urination, and pelvic pain as direct residuals of my radiation treatment. I now require catheterization twice daily and use protective pads at all times.”

What the examiner listens for:

Diagnosis confirmation, treatment dates, current disease status, residual symptoms attributable to the malignancy or its treatment, whether rating should shift to residuals basis.

Understatements to avoid:

Do not assume the examiner has reviewed all your oncology records. Bring documentation of diagnosis, treatment, and current status. Do not minimize residual symptoms from treatment.

Common Mistakes to Avoid

Prep Checklist

0/24 complete

Before Your Exam

Day Of

During the Exam

After the Exam

Your Rights During a C&P Exam

  • You have the right to have your C&P examination conducted by a qualified examiner with appropriate expertise in genitourinary conditions. If the examiner lacks relevant qualifications for your specific condition, you may request a specialist examiner through your VSO.
  • You have the right to bring all relevant medical records to your C&P examination and to offer them to the examiner for review. Do not assume the examiner has already reviewed all your records.
  • You have the right to record your C&P examination in most states where one-party or two-party consent laws permit. Research your state's law before the exam. Notify the examiner at the start of the appointment if you intend to record.
  • You have the right to request a copy of the completed DBQ and all examination reports associated with your claim. These can be obtained through your VSO, a FOIA request, or via your ebenefits/VA.gov records.
  • You have the right to challenge an inadequate C&P examination. If the exam was rushed, the examiner did not ask about key symptoms, did not review records, or the opinion is not supported by the clinical findings, you can request a new examination through your VSO or by filing a Notice of Disagreement.
  • You have the right to submit a personal statement, buddy statements (VA Form 21-10210), and lay evidence describing your symptoms and their impact. Lay evidence is legally competent evidence under 38 CFR 3.303 and must be considered by VA adjudicators.
  • You have the right to a rating that reflects your condition on its worst days, not only how you presented on the specific day of the exam. Per M21-1 guidance, the examiner should consider the full picture of your disability including flare-ups and worst-day presentations.
  • You have the right to bring a support person or advocate to your C&P examination, though they may be asked to wait in the waiting area during the clinical portion of the exam. Check with the exam facility in advance.
  • Under the PACT Act and other VA regulations, you may have presumptive service connection for certain genitourinary cancers related to toxic exposure. If you have not filed for presumptive service connection and have a qualifying malignancy, consult your VSO immediately.
  • If your malignant genitourinary condition (DC 7528) is active, you are entitled to a 100% rating for the duration of active treatment. This rating should not be reduced unless VA follows proper procedural protections including advance notice and a new examination showing sustained improvement.

Get Personalized C&P Exam Preparation

Upload your medical records for AI-powered prep that maps YOUR symptoms to the exact DBQ fields your examiner will evaluate.

This C&P exam preparation guide is for educational purposes only and does not constitute legal, medical, or claims advice. Always consult with a qualified Veterans Service Organization (VSO) representative or VA-accredited attorney for guidance specific to your claim. Never exaggerate, minimize, or fabricate symptoms during a C&P examination.